LIBERTY CORNER, N.J., Aug. 8 /PRNewswire/ -- GeneraMedix Inc. has launched Fosphenytoin Sodium Injection, USP.
GeneraMedix offers Fosphenytoin Sodium Injection, USP, 50 mg PE*/mL in 2 and 10 mL vials, preservative free.
Ronald F. Quadrel, President and CEO of GeneraMedix Inc. stated, "Fosphenytoin represents our fifth generic injectable product launch in the last two months. Our portfolio of product offerings continues to grow at a very rapid pace. We are continuing to develop and file additional Abbreviated New Drug Applications (ANDAs) for many other generic injectables and expect to further expand and diversify our injectable product line."
About GeneraMedix Inc.
GeneraMedix Inc. is a privately held pharmaceutical company offering high quality generic injectable products to the U.S. hospital and specialty markets. In addition to its products already marketed, GeneraMedix has a significant number of injectable products under development, as well as a number of products currently under FDA review. Headquartered in Liberty Corner, New Jersey, the company was founded in July of 2004. Additional information is available on the company's website at www.generamedix.com.
* PE = phenytoin sodium equivalent.
GeneraMedix Inc.CONTACT: Dennis M. Potter of GeneraMedix Inc., +1-908-504-1303,dpotter@generamedix.com
Web site: http://www.generamedix.com//
